The study aimed to compare the duration to complete or partial response (CR/PR) and the
overall response rates (ORR) after six months of neoadjuvant endocrine therapy between
pre-menopausal group and post-menopausal group with highly endocrine responsive operable
mammary carcinoma.
Phase:
Phase 2
Details
Lead Sponsor:
Guangdong General Hospital Guangdong Provincial People's Hospital